Treatment of Pertussis (Whooping Cough)
Azithromycin is the first-line treatment for pertussis due to its once-daily dosing, excellent tolerability, and shorter treatment duration compared to other antibiotics. 1
Antimicrobial Treatment Options
First-Line Treatment: Azithromycin
- Adults: 500 mg on day 1, then 250 mg daily for 4 days (5 days total) 1
- Children: 10 mg/kg on day 1, then 5 mg/kg daily for 4 days (5 days total) 1
- Benefits: Once-daily dosing, excellent tolerability, shorter treatment duration 1, 2
Alternative Options:
Erythromycin
- Adults: 500 mg every 12 hours or 250 mg four times daily for 14 days 3
- Children: 40-50 mg/kg/day in divided doses for 14 days 3
- Limitations:
Clarithromycin
- Adults: 1 g per day in two divided doses for 7 days 4
- Children >1 month: 15 mg/kg per day (maximum: 1 g per day) in 2 divided doses for 7 days 4
- Not recommended for infants <1 month due to potential association with IHPS 4
Trimethoprim-Sulfamethoxazole (TMP-SMZ)
- Used as an alternative when macrolides are contraindicated 1
- Contraindicated in:
- Infants under 2 months
- Pregnant women
- Nursing mothers 1
Treatment Timing and Duration
- Early treatment (within first few weeks of illness) is crucial to:
- Diminish coughing paroxysms
- Prevent disease spread 1
- Standard treatment duration:
Special Considerations
Age-Specific Concerns
- Infants <1 month: Avoid erythromycin if possible due to risk of infantile hypertrophic pyloric stenosis; azithromycin preferred 4, 1
- Infants <2 months: TMP-SMZ contraindicated 1
Treatment Failures
- Some young infants may have persistently positive B. pertussis PCR despite 7 days of clarithromycin treatment 5
- Consider extending treatment or switching antibiotics if symptoms persist
Infection Control Measures
- Isolate patients for 5 days from the start of antimicrobial therapy 1
- Healthcare workers should be excluded from work until 5 days after starting appropriate therapy 1
- Employ droplet precautions for hospitalized patients 1
What NOT to Offer
The following treatments show no evidence of benefit in pertussis and should not be used 1:
- Long-acting β-agonists
- Antihistamines
- Corticosteroids
- Pertussis immunoglobulin
Prevention Strategies
- Post-exposure prophylaxis with the same antimicrobial regimens as for treatment for all close contacts 1
- Vaccination remains the most effective prevention strategy:
Remember that early treatment is essential for reducing symptom severity and preventing transmission, but antimicrobial therapy may have limited effect on the course of illness if started late in the disease.